From: Early detection of peripheral neuropathy in patients with diabetes mellitus type 2
Variable | Group | Mean ± S. D | F | p | ||
---|---|---|---|---|---|---|
Total thickness (μm) | Group 1 | 110.70 ± 3.04 | 271.978 | 0.001* | P1 | 0.001* |
Group 2 | 105.28 ± 5.68 | P2 | 0.001* | |||
Group 3 | 79.33 ± 4.53 | P3 | 0.001* | |||
Superior RNFL (μm) | Group 1 | 114.32 ± 5.42 | 0.842 | 0.436 | P1 | 0.645 |
Group 2 | 113.35 ± 5.81 | P2 | 0.416 | |||
Group 3 | 116.04 ± 8.32 | P3 | 0.205 | |||
Inferior RNFL (μm) | Group 1 | 109.54 ± 2.11 | 2675.600 | 0.001* | P1 | 0.001* |
Group 2 | 99.45 ± 1.90 | P2 | 0.001* | |||
Group 3 | 67.87 ± 1.59 | P3 | 0.001* | |||
Temporal RNFL (μm) | Group 1 | 115.48 ± 3.43 | 2441.391 | 0.001* | P1 | 0.001* |
Group 2 | 98.15 ± 2.45 | P2 | 0.001* | |||
Group 3 | 49.70 ± 3.29 | P3 | 0.001* | |||
Nasal RNFL (μm) | Group 1 | 103.24 ± 2.72 | 0.133 | 0.876 | P1 | 0.838 |
Group 2 | 103.07 ± 3.02 | P2 | 0.611 | |||
Group 3 | 102.82 ± 2.07 | P3 | 0.760 |